Year |
Citation |
Score |
2019 |
Dong H, Tulley S, Zhao Q, Cho L, Chen D, Pearl ML, Chen WT. The propensity of invasive circulating tumor cells (iCTCs) in metastatic progression and therapeutic responsiveness. Cancer Medicine. PMID 31115187 DOI: 10.1002/Cam4.2218 |
0.548 |
|
2017 |
Pearl ML, Dong H, Zhao Q, Tulley S, Dombroff MK, Chen WT. iCTC drug resistance (CDR) Testing ex vivo for evaluation of available therapies to treat patients with epithelial ovarian cancer. Gynecologic Oncology. PMID 28830645 DOI: 10.1016/J.Ygyno.2017.08.018 |
0.459 |
|
2016 |
Tulley S, Zhao Q, Dong H, Pearl ML, Chen WT. Vita-Assay™ Method of Enrichment and Identification of Circulating Cancer Cells/Circulating Tumor Cells (CTCs). Methods in Molecular Biology (Clifton, N.J.). 1406: 107-19. PMID 26820949 DOI: 10.1007/978-1-4939-3444-7_9 |
0.551 |
|
2015 |
Pearl ML, Dong H, Tulley S, Zhao Q, Golightly M, Zucker S, Chen WT. Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs). Gynecologic Oncology. 137: 229-38. PMID 25769657 DOI: 10.1016/J.Ygyno.2015.03.002 |
0.562 |
|
2014 |
Pearl ML, Zhao Q, Yang J, Dong H, Tulley S, Zhang Q, Golightly M, Zucker S, Chen WT. Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer. Gynecologic Oncology. 134: 581-90. PMID 24972191 DOI: 10.1016/J.Ygyno.2014.06.013 |
0.561 |
|
2014 |
Tulley S, Chen WT. Transcriptional regulation of seprase in invasive melanoma cells by transforming growth factor-β signaling. The Journal of Biological Chemistry. 289: 15280-96. PMID 24727589 DOI: 10.1074/Jbc.M114.568501 |
0.364 |
|
2005 |
Kang Y, He W, Tulley S, Gupta GP, Serganova I, Chen CR, Manova-Todorova K, Blasberg R, Gerald WL, Massagué J. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proceedings of the National Academy of Sciences of the United States of America. 102: 13909-14. PMID 16172383 DOI: 10.1073/Pnas.0506517102 |
0.379 |
|
Show low-probability matches. |